Ipocrisia eroina Ewell polo trial nejm fango foglia Senatore
Cancer Clinical Trial Interpretation Videos - YouTube
Neoadjuvant Chemotherapy for Resectable Colorectal Cancer Liver Metastases: Indications and Results | SpringerLink
Hypothermic Machine Perfusion in Liver Transplantation — A Randomized Trial | NEJM
Sotorasib in KRAS p.G12C–Mutated Advanced Pancreatic Cancer | NEJM
David Vivas on X: "🚨SECURE TRIAL now on NEJM! Polypill better than usual care in secondary prevention after MI! Spanish Investigation on top of @escardio 🇪🇸 Congrats Dr Castellano @CNIC_CARDIO and thnks
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk | NEJM
10 1056@NEJMoa2028220 PDF | PDF | Myocardial Infarction | High Density Lipoprotein
Risk of Major Gastrointestinal Bleeding With New vs Conventional Oral Anticoagulants: A Systematic Review and Meta-analysis - ScienceDirect
Phase 3 Trial of Nemolizumab in Patients with Prurigo Nodularis | NEJM
PROpel Trial Efficacy – LYNPARZA® (olaparib) for BRCAm mCRPC
A che punto siamo con gli studi clinici randomizzati controllati (RCT)? - Area Farmacisti - Farmacie Comunali Riunite
Asco 2019 – Polo reveals an overall survival hole | Evaluate
Noninvasive Imaging Heisenberg Research Group – Heisenberg Radiology Research group of Marc Dewey
Servizio Bibliotecario d'Ateneo - Biblioteca Polo San Paolo
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine | NEJM
Current Oncology | Free Full-Text | Olaparib versus Placebo in Maintenance Treatment of Germline BRCA-Mutated Metastatic Pancreatic Cancer: A Cost–Utility Analysis from the Canadian Public Payer’s Perspective
PDF) Olaparib Maintenance Therapy in Patients With Platinum-Sensitive Relapsed Serous Ovarian Cancer
Diapositiva 1
Semaglutide in Patients with Heart Failure with Preserved Ejection Fraction and Obesity | NEJM
Daniel Meyerkort on LinkedIn: #exercise #jointreplacement #tkr #diet #prehab
Maintenance Olaparib for Germline BRCA-Mutated Metastatic Pancreatic Cancer | NEJM
Trial of a Preferential Phosphodiesterase 4B Inhibitor for Idiopathic Pulmonary Fibrosis | NEJM
Overall Survival Results From the POLO Trial: A Phase III Study of Active Maintenance Olaparib Versus Placebo for Germline BRCA-Mutated Metastatic Pancreatic Cancer | Journal of Clinical Oncology